These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4643245)

  • 81. [Preliminary note on histologic changes induced by a new synthetic gestagen (19-nor-17-alpha-hydroxyprogesterone capronate) on adenocarcinoma of the endometrium].
    Vecchione A; Ruozi Berretta L
    Riv Anat Patol Oncol; 1968; 33():431-60. PubMed ID: 5760166
    [No Abstract]   [Full Text] [Related]  

  • 82. A trial of continuous-infusion vinblastine in refractory endometrial adenocarcinoma.
    Kavanagh JJ; Saul PB; Wharton JT; Rutledge FN
    Gynecol Oncol; 1987 Feb; 26(2):236-9. PubMed ID: 3804040
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Synthetic progestational hormones in high doses in adenocarcinoma of the endometrium. (Study of carbohydrate metabolism)].
    Pasquinucci C
    Minerva Ginecol; 1970 Oct; 22(19):950-6. PubMed ID: 5516459
    [No Abstract]   [Full Text] [Related]  

  • 84. Progestational therapy and metastatic adenocarcinoma of the body of the uterus.
    Mackay EV
    Med J Aust; 1969 Feb; 1(5):230-1. PubMed ID: 5781642
    [No Abstract]   [Full Text] [Related]  

  • 85. Mitoxantrone therapy of advanced adenocarcinoma of the endometrium. A phase II trial.
    Runge HM; Meerpohl HG; Pfleiderer A
    Onkologie; 1989 Apr; 12(2):102-3. PubMed ID: 2660047
    [No Abstract]   [Full Text] [Related]  

  • 86. [A case of agranulocytosis following use of thio-TEPA].
    Vagina OG; Vasiliev AK
    Pediatr Akus Ginekol; 1972 Oct; 5():61-2. PubMed ID: 4633307
    [No Abstract]   [Full Text] [Related]  

  • 87. [Hormonally treated corpus carcinoma and its in vitro metabolism of glucose].
    Hackl H
    Arch Gynakol; 1968; 206(3):252-66. PubMed ID: 5755861
    [No Abstract]   [Full Text] [Related]  

  • 88. [On the effect of norhydroxyprogesterone capronate on adenocarcinoma of the corpus uteri in tissue culture].
    Heckmann U
    Dtsch Med Wochenschr; 1965 Dec; 90(52):2328-30. PubMed ID: 5851381
    [No Abstract]   [Full Text] [Related]  

  • 89. Favorable response of metastatic adenocarcinoma of the corpus to massive progrestational therapy: report of a case.
    FRICK HC; SOUTHAM AL; AZAR HA
    Bull Sloane Hosp Women Columbia Presbyt Med; 1963; 9():10-6. PubMed ID: 13959698
    [No Abstract]   [Full Text] [Related]  

  • 90. Adenocarcinoma of the corpus uteri.
    Selim MA; Neuman MR; Razi A; Topolnicki W
    Ohio State Med J; 1976 Nov; 72(11):667-72. PubMed ID: 980294
    [No Abstract]   [Full Text] [Related]  

  • 91. Adjuvant chemotherapy for cancer of the corpus uteri. Preliminary report.
    Lewis GC; Nadler SH; Bross ID; Slack NH
    Obstet Gynecol; 1967 Jun; 29(6):797-802. PubMed ID: 5338150
    [No Abstract]   [Full Text] [Related]  

  • 92. [Hormonal treatment of uterine corpus carcinoma (our personal experience)].
    Zielonka I; Kwaśniewska-Rokicińska C
    Nowotwory; 1977; 27(1):67-71. PubMed ID: 558605
    [No Abstract]   [Full Text] [Related]  

  • 93. [Results obtained from gestagen treatment of patients for endometrial carcinoma, with particular reference to results obtained from in vitro tests before treatment (author's transl)].
    Schindler C; Schober J
    Zentralbl Gynakol; 1981; 103(12):703-7. PubMed ID: 7282171
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Effect of treatment with synthetic progestins on indices of the liver protein-forming function in uterine cancer patients].
    Shvedova LA
    Akush Ginekol (Mosk); 1984 Apr; (4):51-2. PubMed ID: 6742352
    [No Abstract]   [Full Text] [Related]  

  • 95. [Treatment of cancer of the corpus uteri with luteal hormone].
    Shimada N
    Josanpu Zasshi; 1975 Nov; 28(11):609. PubMed ID: 1037863
    [No Abstract]   [Full Text] [Related]  

  • 96. The action of norhydroxyprogesterone capronate on endometrial carcinoma in tissue culture.
    Heckmann U
    Ger Med Mon; 1966 Feb; 11(2):48-9. PubMed ID: 5930216
    [No Abstract]   [Full Text] [Related]  

  • 97. Local use of progestogen in cancer.
    Craft IL
    Br Med J; 1969 Jul; 3(5662):115. PubMed ID: 5790259
    [No Abstract]   [Full Text] [Related]  

  • 98. [CLINICAL ASPECTS OF METASTATIC TUMORS OF THE CORPUS UTERI].
    SCHWARZ S; HELBICH A; OLSZEWSKI Z
    Nowotwory; 1964; 14():131-5. PubMed ID: 14220349
    [No Abstract]   [Full Text] [Related]  

  • 99. [Cytological studies of adenocarcinoma of corpus uteri].
    WIED GL
    Geburtshilfe Frauenheilkd; 1953 Jun; 13(6):492-503. PubMed ID: 13083887
    [No Abstract]   [Full Text] [Related]  

  • 100. Adenocarcinoma of the corpus uteri.
    SHAW HN
    Calif Med; 1949 Jun; 70(6):498. PubMed ID: 18131689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.